Registration Dossier

Administrative data

Link to relevant study record(s)

Description of key information

Key value for chemical safety assessment

Additional information

The urinary excretion of unmetabolized sulfolane was studied in male Sprague-Dawley rats from a single intravenous injection of 500 or 1,000 mg/kg sulfolane (Andersen et al., 1976). The proportion of dose excreted unchanged increased as the dosage was increased. In a separate set of experiments, the elimination of sulfolane from the blood was determined in a rabbit, dog and squirrel monkey following a single intravenous doses of sulfolane. Sulfolane was rapidly distributed with volumes of distribution of about 1.0 L/kg; the elimination half-life was 3.5 to 5 hours. 

Andersen, M.E., Jones, R.A., Kurlansik, L., Mehl, R.G., and Jenkins, L.J., Jr. (1976) Sulfolane-induced convulsions in rodents. Res. Commun. Chem. Pathol. Pharmacol. 15: 571-580.

[35S]-Sulfolane (100 mg) was injected intraperitoneally into three male Wistar rats and the 24-hour urinary samples were analysed (Roberts and Warwick, 1961). One major metabolite was excreted, constituting at least 85% of the urinary radioactivity. It was identified as 3-hydroxysulfolane. 

Roberts, J.J., and Warwick, G.P. (1961) The mode of action of alkylating agents – III The formation of 3-hydroxytetrahydrothiophene-1;1-dioxide from 1:4-dimethylsulphonyloxybutane (Myleran), S-β-L-alanyltetrahydrothiophenium mesylate, tetrahydrothiophene and tetrahydrothiophene-1:1-dioxide in the rat, rabbit and mouse. Biochem. Pharmacol. 6: 217-227.